Provided by Tiger Trade Technology Pte. Ltd.

PMV Pharmaceuticals

1.38
0.0000
Volume:120.99K
Turnover:166.01K
Market Cap:103.83M
PE:-0.97
High:1.40
Open:1.37
Low:1.35
Close:1.38
52wk High:1.88
52wk Low:1.02
Shares:75.51M
Float Shares:68.38M
Volume Ratio:1.36
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4131
EPS(LYR):-1.4800
ROE:-70.93%
ROA:-42.39%
PB:1.45
PE(LYR):-0.93

Loading ...

Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jun 09, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Jan 28, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 25, 2024

Correspondence

Form CORRESP - Correspondence
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mar 01, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2024

Major Issues Report

Form 8-K - Current report